Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EHAB
3526
DELISTED
Enhabit
EHAB
| $819K | ﹤0.01% |
88,810
+9,191
| +12% | +$79.6K |
|
3527
Design Therapeutics
DSGN
$913M
| $817K | ﹤0.01% |
87,060
-1,116
| -1% | -$8.74K |
|
3528
Talkspace
TALK
$871M
| $816K | ﹤0.01% |
224,707
+18,378
| +9% | +$58.3K |
|
3529
Weave Communications
WEAV
$400M
| $814K | ﹤0.01% |
107,227
+23,743
| +28% | +$158K |
|
3530
FTAI Infrastructure
FIP
$546M
| $813K | ﹤0.01% |
176,354
+16,744
| +10% | +$82.5K |
|
3531
PUT
Xerox
XRX
$411M
| $812K | ﹤0.01% |
342,500
-47,500
| -12% | -$141K |
|
3532
PUT
PENN Entertainment
PENN
$2.52B
| $811K | ﹤0.01% |
55,000
| – | – |
|
3533
Tronox
TROX
$965M
| $810K | ﹤0.01% |
194,255
+13,649
| +8% | +$52K |
|
3534
Backblaze
BLZE
$1.25B
| $808K | ﹤0.01% |
173,391
+5,101
| +3% | +$35K |
|
3535
Bloomin' Brands
BLMN
$938M
| $808K | ﹤0.01% |
130,922
+12,000
| +10% | +$83.6K |
|
3536
OppFi
OPFI
$604M
| $803K | ﹤0.01% |
76,723
+38,330
| +100% | +$389K |
|
|
XIFR
3537
XPLR Infrastructure LP
XIFR
$1.09B
| $801K | ﹤0.01% |
80,100
+48,287
| +152% | +$468K |
|
3538
Gray Television
GTN
$511M
| $801K | ﹤0.01% |
165,457
+12,497
| +8% | +$61.2K |
|
3539
TIM SA
TIMB
$8.33B
| $800K | ﹤0.01% |
41,149
+18,501
| +82% | +$406K |
|
|
STKL
3540
DELISTED
SunOpta
STKL
| $799K | ﹤0.01% |
210,388
+26,269
| +14% | +$119K |
|
3541
Farmers National Banc Corp
FMNB
$966M
| $797K | ﹤0.01% |
59,819
+7,437
| +14% | +$102K |
|
|
ASM
3542
Avino Silver & Gold Mines
ASM
$1.21B
| $796K | ﹤0.01% |
128,205
-9,000
| -7% | -$48.4K |
|
3543
Arrow Financial
AROW
$726M
| $796K | ﹤0.01% |
25,339
+2,143
| +9% | +$63.4K |
|
3544
Oportun Financial
OPRT
$356M
| $793K | ﹤0.01% |
149,925
+53,954
| +56% | +$285K |
|
3545
Dakota Gold
DC
$818M
| $793K | ﹤0.01% |
139,584
+16,405
| +13% | +$78.8K |
|
3546
Delcath Systems
DCTH
$593M
| $793K | ﹤0.01% |
78,487
+22,491
| +40% | +$224K |
|
3547
iShares MSCI Japan ETF
EWJ
$23.2B
| $792K | ﹤0.01% |
9,809
+3,813
| +64% | +$313K |
|
3548
Krispy Kreme
DNUT
$571M
| $789K | ﹤0.01% |
196,303
+85,783
| +78% | +$340K |
|
3549
Sabre
SABR
$868M
| $786K | ﹤0.01% |
578,245
-1,003
| -0.2% | -$1.73K |
|
3550
AerSale
ASLE
$272M
| $786K | ﹤0.01% |
110,598
-750
| -0.7% | -$5.27K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.